Coagulopathy in trauma: Optimising haematological status

Trauma

Volumn 10, Issue 2, 2008, Pages 109-123

  Mcdonald, Vickie ^a   Ryland, Kim ^a  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

Coagulopathy; fibrinogen; fresh frozen plasma; lethal triad; platelets; rVIIa; transfusion; trauma

Indexed keywords

AMINOCAPROIC ACID; ANTIFIBRINOLYTIC AGENT; APROTININ; FIBRINOGEN; FRESH FROZEN PLASMA; HAEMOCOMPLETTAN P; LOW MOLECULAR WEIGHT HEPARIN; OCTAPLEX; PLACEBO; PROTEIN C; PROTHROMBIN COMPLEX; RECOMBINANT BLOOD CLOTTING FACTOR 7A; TRANEXAMIC ACID;

ADJUVANT THERAPY; ANEMIA; BLEEDING; BLEEDING TIME; BLOOD CLOTTING; BLOOD CLOTTING DISORDER; BLOOD TRANSFUSION; BRAIN DISEASE; CAUSE OF DEATH; CLINICAL ASSESSMENT; CLINICAL TRIAL; DISSEMINATED INTRAVASCULAR CLOTTING; DRUG EFFICACY; DRUG HALF LIFE; DRUG MECHANISM; EARLY INTERVENTION; ERYTHROCYTE CONCENTRATE; ERYTHROCYTE TRANSFUSION; EVIDENCE BASED MEDICINE; FIBRINOLYSIS; HEART FAILURE; HEMATOLOGICAL PARAMETERS; HEMOSTASIS; HUMAN; HYPOTHERMIA; INJURY; KIDNEY FAILURE; LABORATORY TEST; LOW DRUG DOSE; METABOLIC ACIDOSIS; MORTALITY; NONHUMAN; PATHOGENESIS; PATHOPHYSIOLOGY; POSTOPERATIVE HEMORRHAGE; RECOMMENDED DRUG DOSE; REVIEW; THROMBOCYTE TRANSFUSION; THROMBOELASTOGRAPHY; THROMBOEMBOLISM; THROMBOSIS PREVENTION; UNITED KINGDOM;

EID: 44949154606     PISSN: 14604086     EISSN: None     Source Type: Journal    
DOI: 10.1177/1460408608091266     Document Type: Article

References (121)

1. Azu MC, McCormack JE, Huang EC, Lee TK, Shapiro MJ 2007. Venous thromboembolic events in hospitalized trauma patients. Am Surg 73: 1228-31.
2. Bauza G., Hirsch E., Burke P., Quillen K. 2007. Low-dose recombinant activated factor VII in massively transfused trauma patients with coagulopathy. Transfusion 47: 749-51.
3. Bickell WH, Wall Jr MJ, Pepe PE, Martin RR, Ginger VF, Allen MK, Mattox KL 1994. Immediate versus delayed fluid resuscitation for hypotensive patients with penetrating torso injuries. N Engl J Med 331: 1105-09.
4. Boffard KD, Riou B., Warren B., Choong PI, Rizoli S., Rossaint R., Axelsen M., Kluger Y. 2005. Recombinant factor VIIa as adjunctive therapy for bleeding control in severely injured trauma patients: two parallel randomized, placebo-controlled, double-blind clinical trials. J Trauma 59: 8-15.
5. Brohi K., Cohen MJ, Davenport RA 2007a. Acute coagulopathy of trauma: mechanism, identification and effect. Curr Opin Crit Care 13: 680-85.
6. Brohi K., Cohen MJ, Ganter MT, Matthay MA, Mackersie RC, Pittet JF 2007b. Acute traumatic coagulopathy: initiated by hypoperfusion: modulated through the protein C pathway? Ann Surg 245: 812-18.
7. Brohi K., Singh J., Heron M., Coats T. 2003. Acute traumatic coagulopathy. J Trauma 54: 1127-30.
8. Brummel-Ziedins K., Whelihan MF, Ziedins EG, Mann KG 2006. The resuscitative fluid you choose may potentiate bleeding. J Trauma 61: 1350-58.
9. CDC: Web-Based Injury Statistics Query and Reporting System (WISQARS). 2002. US Department of Health and Human Services, CDC, National Centre for Injury Prevention and Control.
10. Coats T., Roberts I., Shakur H. 2004. Antifibrinolytic drugs for acute traumatic injury. Cochrane Database Syst Rev, CD004896.
11. Consensus conference. Platelet transfusion therapy. 1987. JAMA 257: 1777-80.
12. Cosgriff N., Moore EE, Sauaia A., Kenny-Moynihan M., Burch JM, Galloway B. 1997. Predicting life-threatening coagulopathy in the massively transfused trauma patient: hypothermia and acidoses revisited. J Trauma 42: 857-61.
13. Counts RB, Haisch C., Simon TL, Maxwell NG, Heimbach DM, Carrico CJ 1979. Hemostasis in massively transfused trauma patients. Ann Surg 190: 91-99.
14. de Jonge E., Levi M. 2001. Effects of different plasma substitutes on blood coagulation: a comparative review. Crit Care Med 29: 1261-67.
15. De Waele JJ, Van CS, Hoste E., Benoit D., Colardyn F. 2003. The use of the activated clotting time for monitoring heparin therapy in critically ill patients. Intensive Care Med 29: 325-28.
16. Durham RM, Moran JJ, Mazuski JE, Shapiro MJ, Baue AE, Flint LM 2003. Multiple organ failure in trauma patients. J Trauma 55: 608-16.
17. Dutton RP, Carson JL 2006. Indications for early red blood cell transfusion. J Trauma 60: S35-S40.
18. Dutton RP, McCunn M., Hyder M., D'Angelo M., O'Connor J., Hess JR, Scalea TM 2004. Factor VIIa for correction of traumatic coagulopathy. J Trauma 57: 709-18.
19. Engstrom M., Schott U., Romner B., Reinstrup P. 2006. Acidosis impairs the coagulation: A thromboelastographic study. J Trauma 61: 624-28.
20. Fakhry SM, Sheldon GF 1994. Massive transfusion in the surgical patient. In: Jeffries LC, Brecher ME eds. Massive Transfusion American Association of Blood Banks, Bethesda, MD, USA.
21. Fenger-Eriksen C., nker-Moller E., Heslop J., Ingerslev J., Sorensen B. 2005. Thrombelastographic whole blood clot formation after ex vivo addition of plasma substitutes: improvements of the induced coagulopathy with fibrinogen concentrate. Br J Anaesth 94: 324-29.
22. Ferrara A., MacArthur JD, Wright HK, Modlin IM, McMillen MA 1990. Hypothermia and acidosis worsen coagulopathy in the patient requiring massive transfusion. Am J Surg 160: 515-18.
23. Franklin GA, Boaz PW, Spain DA, Lukan JK, Carrillo EH, Richardson JD 2000. Prehospital hypotension as a valid indicator of trauma team activation. J Trauma 48: 1034-37.
24. Fries D., Innerhofer P., Klingler A., Berresheim U., Mittermayr M., Calatzis A., Schobersberger W. 2002. The effect of the combined administration of colloids and lactated Ringer's solution on the coagulation system: an in vitro study using thrombelastograph coagulation analysis (ROTEG). Anesth Analg 94: 1280-87.
25. Fries D., Krismer A., Klingler A., Streif W., Klima G., Wenzel V., Haas T., Innerhofer P. 2005. Effect of fibrinogen on reversal of dilutional coagulopathy: a porcine model. Br J Anaesth 95: 172-77.
26. Gabriel DA, Li X., Monroe III DM, Roberts HR 2004. Recombinant human factor VIIa (rFVIIa) can activate factor FIX on activated platelets. J Thromb Haemost 2: 1816-22.
27. Ganter MT, Brohi K., Cohen MJ, Shaffer LA, Walsh MC, Stahl GL, Pittet JF 2007. Role of the alternative pathway in the early complement activation following major trauma. Shock 28: 29-34.
28. Geerts WH, Code KI, Jay RM, Chen E., Szalai JP 1994. A prospective study of venous thromboembolism after major trauma. N Engl J Med 331: 1601-06.
29. Geerts WH, Pineo GF, Heit JA, Bergqvist D., Lassen MR, Colwell CW, Ray JG 2004. Prevention of venous thromboembolism: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy. Chest 126: 338S-400S.
30. Gentilello LM, Pierson DJ 2001. Trauma critical care. Am J Respir Crit Care Med 163: 604-07.
31. Gilabert J., Estelles A., Aznar J., Galbis M. 1985. Abruptio placentae and disseminated intravascular coagulation. Acta Obstet Gynecol Scand 64: 35-9. Goodnight SH, Hathaway WE 2001. Haemostasis and Thrombosis, 2nd edn, Vol. 3, McGraw-Hill, Medical publishing division, USA.
32. Hardy JF, de MP, Samama CM 2006. Massive transfusion and coagulopathy: pathophysiology and implications for clinical management. Can J Anaesth 53: S40-S58.
33. Hartert H. 1948. Blutgeinnung studien mit der thromboelastographie, einen neuen untersuchingsverfahren. Kiln Wochenschrift 26: 577-83.
34. Hebert PC, Wells G., Blajchman MA, Marshall J., Martin C., Pagliarello G., Tweeddale M., Schweitzer I., Yetisir E. 1999. A multicenter, randomized, controlled clinical trial of transfusion requirements in critical care. Transfusion Requirements in Critical Care Investigators, Canadian Critical Care Trials Group. N Engl J Med 340: 409-17.
35. Heckbert SR, Vedder NB, Hoffman W., Winn RK, Hudson LD, Jurkovich GJ, Copass MK, Harlan JM, Rice CL, Maier RV 1998. Outcome after hemorrhagic shock in trauma patients. J Trauma 45: 545-49.
36. Hellem AJ, Borchgrevink CF, Ames SB 1961. The role of red cells in haemostasis: the relation between haematocrit, bleeding time and platelet adhesiveness. Br J Haematol 7: 42-50.
37. Henry DA, Moxey AJ, Carless PA, O'Connell D., McClelland B., Henderson KM, Sly K., Laupacis A., Fergusson D. 2001. Anti-fibrinolytic use for minimising perioperative allogeneic blood transfusion. Cochrane Database Syst Rev, CD001886.
38. Hensler T., Heinemann B., Sauerland S., Lefering R., Bouillon B., Andermahr J., Neugebauer EA 2003. Immunologic alterations associated with high blood transfusion volume after multiple injury: effects on plasmatic cytokine and cytokine receptor concentrations. Shock 20: 497-502.
39. Hess JR 2007. Blood and coagulation support in trauma care. Hematology Am Soc Hematol Educ Program 2007: 187-91.
40. Hiippala S. 1998. Replacement of massive blood loss. Vox Sang 74(Suppl 2): 399-407.
41. Hirshberg A., Dugas M., Banez EI, Scott BG, Wall Jr MJ, Mattox KL 2003. Minimizing dilutional coagulopathy in exsanguinating hemorrhage: a computer simulation. J Trauma 54: 454-63.
42. Ho AM, Dion PW, Cheng CA, Karmakar MK, Cheng G., Peng Z., Ng YW 2005. A mathematical model for fresh frozen plasma transfusion strategies during major trauma resuscitation with ongoing hemorrhage. Can J Surg 48: 470-78.
43. Hoffman M., Monroe III DM 2001. A cell-based model of hemostasis. Thromb Haemost 85: 958-65.
44. Holcomb JB 2004. Methods for improved hemorrhage control. Critical Care 8: S57-S60.
45. Hoyt DB, Bulger EM, Knudson MM, Morris J., Ierardi R., Sugerman HJ, Shackford SR, Landercasper J., Winchell RJ, Jurkovich G. 1994. Death in the operating room: an analysis of a multicenter experience. J Trauma 37: 426-32.
46. Hulka F., Mullins RJ, Frank EH 1996. Blunt brain injury activates the coagulation process. Arch. Surg 131: 923-27.
47. Iselin BM, Willimann PF, Seifert B., Casutt M., Bombeli T., Zalunardo MP, Pasch T., Spahn DR 2001. Isolated reduction of haematocrit does not compromise in vitro blood coagulation. Br J Anaesth 87: 246-49.
48. Iwata H., Kaibara M. 2002. Activation of factor IX by erythrocyte membranes causes intrinsic coagulation. Blood Coagul Fibrinolysis 13: 489-96.
49. Johnston TD, Chen Y., Reed RL 1994. Functional equivalence of hypothermia to specific clotting factor deficiencies. J Trauma 37: 413-17.
50. Kaibara M., Iwata H., Ujiie H., Himeno R., Kaibara M. 2005. Rheological analyses of coagulation of blood from different individuals with special reference to procoagulant activity of erythrocytes. Blood Coagul Fibrinolysis 16: 355-63.
51. Kang YG, Martin DJ, Marquez J., Lewis JH, Bontempo FA, Shaw Jr BW, Starzl TE, Winter PM 1985. Intraoperative changes in blood coagulation and thrombelastographic monitoring in liver transplantation. Anesth Analg 64: 888-96.
52. Kaufmann CR, Dwyer KM, Crews JD, Dols SJ, Trask AL 1997. Usefulness of thrombelastography in assessment of trauma patient coagulation. J Trauma 42: 716-20.
53. Kauvar DS, Lefering R., Wade CE 2006. Impact of hemorrhage on trauma outcome: an overview of epidemiology, clinical presentations, and therapeutic considerations. J Trauma 60: S3-11.
54. Kauvar DS, Wade CE 2005. The epidemiology and modern management of traumatic hemorrhage: US and international perspectives. Crit Care 9(Suppl 5): S1-S9.
55. Kermode JC, Zheng Q., Milner EP 1999. Marked temperature dependence of the platelet calcium signal induced by human von Willebrand factor. Blood 94: 199-207.
56. Ketchum L., Hess JR, Hiippala S. 2006. Indications for early fresh frozen plasma, cryoprecipitate, and platelet transfusion in trauma. J Trauma 60: S51-S58.
57. Klitgaard T., Palacios R., Boffard KD, Iau PT, Warren B., Rizoli S., Rossaint R., Kluger Y., Riou B. 2006. Pharmacokinetics of recombinant activated factor VII in trauma patients with severe bleeding. Crit Care 10: R104.
58. Kooistra T., Schrauwen Y., Arts J., Emeis JJ 1994. Regulation of endothelial cell t-PA synthesis and release. Int J Hematol 59: 233-55.
59. Leslie SD, Toy PT 1991. Laboratory hemostatic abnormalities in massively transfused patients given red blood cells and crystalloid. Am J Clin Pathol 96: 770-73.
60. Levi M. 2007. Disseminated intravascular coagulation. Crit Care Med 35: 2191-95.
61. Luddington RJ 2005. Thrombelastography/ thromboelastometry. Clin Lab Haematol 27: 81-90.
62. Mackie IJ, Kitchen S., Machin SJ, Lowe GD 2003. Guidelines on fibrinogen assays. Br J Haematol 121: 396-404.
63. MacLeod J., Lynn M., McKenney MG, Jeroukhimov I., Cohn SM 2004. Predictors of mortality in trauma patients. Am Surg 70: 805-10.
64. MacLeod JB, Lynn M., McKenney MG, Cohn SM, Murtha M. 2003. Early coagulopathy predicts mortality in trauma. J Trauma 55: 39-44.
65. Malone DL, Dunne J., Tracy JK, Putnam AT, Scalea TM, Napolitano LM 2003. Blood transfusion, independent of shock severity, is associated with worse outcome in trauma. J Trauma 54: 898-905.
66. Mangano DT, Tudor IC, Dietzel C. 2006. The risk associated with aprotinin in cardiac surgery. N Engl J Med 354: 353-65.
67. Manley G., Knudson MM, Morabito D., Damron S., Erickson V., Pitts L. 2001. Hypotension, hypoxia, and head injury: frequency, duration, and consequences. Arch Surg 136: 1118-23.
68. Marietta M., Facchini L., Girardis M., Luppi M., Torelli G. 2006. More on: Platelet count and the use of recombinant factor VIIa for the treatment of bleeding complications after hematopoietic stem cell transplantation. J Thromb Haemost 4: 288.
69. Martini WZ, Chinkes DL, Pusateri AE, Holcomb JB, Yu YM, Zhang XJ, Wolfe RR 2005. Acute changes in fibrinogen metabolism and coagulation after hemorrhage in pigs. Am J Physiol Endocrinol Metab 289: E930-E934.
70. Martini WZ, Dubick MA, Wade CE, Holcomb JB 2007. Evaluation of tris-hydroxymethylaminomethane on reversing coagulation abnormalities caused by acidosis in pigs. Crit Care Med 35: 1568-74.
71. McIntyre L., Hebert PC, Wells G., Fergusson D., Marshall J., Yetisir E., Blajchman MJ 2004. Is a restrictive transfusion strategy safe for resuscitated and critically ill trauma patients? J Trauma 57: 563-68.
72. McNulty SE, Torjman M., Grodecki W., Marr A., Schieren H. 1995. A comparison of four bedside methods of hemoglobin assessment during cardiac surgery. Anesth Analg 81: 1197-202.
73. Meng ZH, Wolberg AS, Monroe III DM, Hoffman M. 2003. The effect of temperature and pH on the activity of factor VIIa: implications for the efficacy of high-dose factor VIIa in hypothermic and acidotic patients. J Trauma 55: 886-91.
74. Michelson AD, MacGregor H., Barnard MR, Kestin AS, Rohrer MJ, Valeri CR 1994. Reversible inhibition of human platelet activation by hypothermia in vivo and in vitro. Thromb Haemost 71: 633-40.
75. Miller RD, Robbins TO, Tong MJ, Barton SL 1971. Coagulation defects associated with massive blood transfusions. Ann Surg 174: 794-801.
76. Mollison PL, Engelfeit CP, Contreras M. 1997. Transfusion in oligaemia. Blood transfusion in clinical medicine Blackwell Science: Oxford: p. 47.
77. Moore FA, Sauaia A., Moore EE, Haenel JB, Burch JM, Lezotte DC 1996. Postinjury multiple organ failure: a bimodal phenomenon. J Trauma 40: 501-10.
78. Norfolk DR, Ancliffe PJ, Contreras M., Hunt BJ, Machin SJ, Murphy WG, Williamson LM 1998. Consensus Conference on Platelet Transfusion, Royal College of Physicians of Edinburgh, 27-28 November 1997. Synopsis of background papers. Br J Haematol 101: 609-17.
79. O'Shaughnessy DF, Atterbury C., Bolton MP, Murphy M., Thomas D., Yates S., Williamson LM 2004c. Guidelines for the use of fresh-frozen plasma, cryoprecipitate and cryosupernatant. Br J Haematol 126: 11-28.
80. O'Shaughnessy DF, Atterbury C., Bolton MP, Murphy M., Thomas D., Yates S., Williamson LM 2004a. Guidelines for the use of fresh-frozen plasma, cryoprecipitate and cryosupernatant. Br J Haematol 126: 11-28.
81. O'Shaughnessy DF, Atterbury C., Bolton MP, Murphy M., Thomas D., Yates S., Williamson LM 2004b. Guidelines for the use of fresh-frozen plasma, cryoprecipitate and cryosupernatant. Br J Haematol 126: 11-28.
82. Oung CM, Li MS, Shum-Tim D., Chiu RC, Hinchey EJ 1993. In vivo study of bleeding time and arterial hemorrhage in hypothermic versus normothermic animals. J Trauma 35: 251-54.
83. Peyrou V., Lormeau JC, Herault JP, Gaich C., Pfliegger AM, Herbert JM 1999. Contribution of erythrocytes to thrombin generation in whole blood. Thromb Haemost 81: 400-06.
84. Pina-Cabral JM, Ribeiro-da-Silva A., meida-Dias A. 1985. Platelet sequestration during hypothermia in dogs treated with sulphinpyrazone and ticlopidine- reversibility accelerated after intra-abdominal rewarming. Thromb Haemost 54: 838-41.
85. Plurad D., Martin M., Green D., Salim A., Inaba K., Belzberg H., Demetriades D., Rhee P. 2007. The decreasing incidence of late posttraumatic acute respiratory distress syndrome: the potential role of lung protective ventilation and conservative transfusion practice. J Trauma 63: 1-7.
86. Practice parameter for the use of fresh-frozen plasma, cryoprecipitate, and platelets. Fresh-frozen plasma, cryoprecipitate, and platelets administration practice guidelines development task force of the college of american pathologists. 1994. JAMA 271: 777-81.
87. Quaknine-Orlando B., Samama CM, Riou B., Bonnin P., Guillosson JJ, Beaumont JL, Coriat P. 1999. Role of the hematocrit in a rabbit model of arterial thrombosis and bleeding. Anesthesiology 90: 1454-61.
88. Reed RL, Johnson TD, Hudson JD, Fischer RP 1992. The disparity between hypothermic coagulopathy and clotting studies. J Trauma 33: 465-70.
89. Rizoli SB, Boffard KD, Riou B., Warren B., Iau P., Kluger Y., Rossaint R., Tillinger M. 2006. Recombinant activated factor VII as an adjunctive therapy for bleeding control in severe trauma patients with coagulopathy: subgroup analysis from two randomized trials. Crit Care 10: R178.
90. Roche AM, James MF, Grocott MP, Mythen MG 2006. Just scratching the surface: varied coagulation effects of polymer containers on TEG variables. Eur J Anaesthesiol 23: 45-9.
91. Rossaint R., Cerny V., Coats TJ, Duranteau J., Fernandez-Mondejar E., Gordini G., Stahel PF, Hunt BJ, Neugebauer E., Spahn DR 2006. Key issues in advanced bleeding care in trauma. Shock 26: 322-31. Royston D., von KS 2001. Reduced haemostatic factor transfusion using heparinase-modified thrombelastography during cardiopulmonary bypass. Br J Anaesth 86: 575-78.
92. Rugeri L., Levrat A., David JS, Delecroix E., Floccard B., Gros A., Allaouchiche B., Negrier C. 2007. Diagnosis of early coagulation abnormalities in trauma patients by rotation thrombelastography. J Thromb Haemost 5: 289-95.
93. Salooja N., Perry DJ 2001. Thrombelastography. Blood Coagul. Fibrinolysis 12: 327-37.
94. Samama CM, Djoudi R., Lecompte T., Nathan-Denizot N., Schved JF 2005. Perioperative platelet transfusion: recommendations of the Agence Francaise de Securite Sanitaire des Produits de Sante (AFSSaPS) 2003. Can J Anaesth 52: 30-7.
95. Santos MT, Valles J., Marcus AJ, Safier LB, Broekman MJ, Islam N., Ullman HL, Eiroa AM, Aznar J. 1991. Enhancement of platelet reactivity and modulation of eicosanoid production by intact erythrocytes. A new approach to platelet activation and recruitment. J Clin Invest 87: 571-80.
96. Sauaia A., Moore FA, Moore EE, Lezotte DC 1996. Early risk factors for postinjury multiple organ failure. World J Surg 20: 392-400.
97. Sauaia A., Moore FA, Moore EE, Moser KS, Brennan R., Read RA, Pons PT 1995a. Epidemiology of Trauma Deaths - A Reassessment. Journal of Trauma-Injury Infection and Critical Care 38: 185-93.
98. Sauaia A., Moore FA, Moore EE, Moser KS, Brennan R., Read RA, Pons PT 1995b. Epidemiology of Trauma Deaths - A Reassessment. Journal of Trauma-Injury Infection and Critical Care 38: 185-93.
99. Schmied H., Kurz A., Sessler DI, Kozek S., Reiter A. 1996. Mild hypothermia increases blood loss and transfusion requirements during total hip arthroplasty. Lancet 347: 289-92.
100. Schneiderman J., Adar R., Savion N. 1991. Changes in plasmatic tissue-type plasminogen activator and plasminogen activator inhibitor activity during acute arterial occlusion associated with severe ischemia. Thromb Res 62: 401-08.
101. Schols SE, van der Meijden PE, van OR, Curvers J., Heemskerk JW, van Pampus EC 2008. Increased thrombin generation and fibrinogen level after therapeutic plasma transfusion: Relation to bleeding. Thromb Haemost 99: 64-70.
102. Schreiber MA, Differding J., Thorborg P., Mayberry JC, Mullins RJ 2005. Hypercoagulability is most prevalent early after injury and in female patients. J Trauma 58: 475-80.
103. Shima M., Tanaka I., Sawamoto Y., Kanehiro H., Matsuo N., Nishimura A., Giddings JC, Yoshioka A. 1997. Successful treatment of two brothers with congenital afibrinogenemia for splenic rupture using heat- and solvent detergent-treated fibrinogen concentrates. J Pediatr Hematol Oncol 19: 462-65.
104. Spahn DR, Cerny V., Coats TJ, Duranteau J., Fernandez-Mondejar E., Gordini G., Stahel PF, Hunt BJ, Komadina R., Neugebauer E., Ozier Y., Riddez L., Schultz A., Vincent JL, Rossaint R. 2007. Management of bleeding following major trauma: a European guideline. Crit Care 11: R17.
105. D., Stainsby, S., MacLennan, P.J., Hamilton, Management of massive blood loss: a template guideline, Br J Anaesth, a., (2000), 85, 487-491
106. Stainsby D., MacLennan S., Hamilton PJ 2000b. Management of massive blood loss: a template guideline. Br J Anaesth 85: 487-91.
107. Stainsby D., MacLennan S., Thomas D., Isaac J., Hamilton PJ 2006. Guidelines on the management of massive blood loss. Br J Haematol 135: 634-41.
108. Stanworth SJ 2007. The Evidence-Based Use of FFP and Cryoprecipitate for Abnormalities of Coagulation Tests and Clinical Coagulopathy. Hematology Am Soc Hematol Educ Program 179-86.
109. Stanworth SJ, Brunskill SJ, Hyde CJ, McClelland DB, Murphy MF 2004. Is fresh frozen plasma clinically effective? A systematic review of randomized controlled trials. Br J Haematol 126: 139-52.
110. Taylor Jr FB, Toh CH, Hoots WK, Wada H., Levi M. 2001. Towards definition, clinical and laboratory criteria, and a scoring system for disseminated intravascular coagulation. Thromb Haemost 86: 1327-30.
111. Valeri CR, Cassidy G., Pivacek LE, Ragno G., Lieberthal W., Crowley JP, Khuri SF, Loscalzo J. 2001. Anemia-induced increase in the bleeding time: implications for treatment of nonsurgical blood loss. Transfusion 41: 977-83.
112. Valeri CR, Feingold H., Cassidy G., Ragno G., Khuri S., Altschule MD 1987. Hypothermia-induced reversible platelet dysfunction. Ann Surg 205: 175-81.
113. Valeri CR, Khabbaz K., Khuri SF, Marquardt C., Ragno G., Feingold H., Gray AD, Axford T. 1992. Effect of skin temperature on platelet function in patients undergoing extracorporeal bypass. J Thorac Cardiovasc Surg 104: 108-16.
114. Velmahos GC, Kern J., Chan LS, Oder D., Murray JA, Shekelle P. 2000. Prevention of venous thromboembolism after injury: an evidence-based report-part II: analysis of risk factors and evaluation of the role of vena caval filters. J Trauma 49: 140-44.
115. Vig S., Chitolie A., Bevan DH, Halliday A., Dormandy J. 2001. Thromboelastography: a reliable test? Blood Coagul Fibrinolysis 12: 555-61.
116. Vincent JL, Rossaint R., Riou B., Ozier Y., Zideman D., Spahn DR 2006. Recommendations on the use of recombinant activated factor VII as an adjunctive treatment for massive bleeding-a European perspective. Crit Care 10: R120.
117. Whitten CW, Greilich PE 2000. Thromboelastography: past, present, and future. Anesthesiology 92: 1223-25.
118. Wolberg AS, Meng ZH, Monroe Dmiii, Hoffman M. 2004. A systematic evaluation of the effect of temperature on coagulation enzyme activity and platelet function. J Trauma 56: 1221-28.
119. Yoshihara H., Yamamoto T., Mihara H. 1985. Changes in coagulation and fibrinolysis occurring in dogs during hypothermia. Thromb Res 37: 503-12.
120. Yuan S., Ferrell C., Chandler WL 2007. Comparing the prothrombin time INR versus the APTT to evaluate the coagulopathy of acute trauma. Thromb Res 120: 29-37.
121. Zambruni A., Thalheimer U., Leandro G., Perry D., Burroughs AK 2004. Thromboelastography with citrated blood: comparability with native blood, stability of citrate storage and effect of repeated sampling. Blood Coagul Fibrinolysis 15: 103-07.